Search

Optogenetic-based neuroprosthetic therapies are increasingly being considered for human trials. However, the optoelectronic design of clinical-grade optogenetic-based neuroprosthetic probes still requires some thought. Design constraints include light penetration into the brain, stimulation efficacy, and probe/tissue heating. Optimisation can be achieved through experimental iteration. However, this is costly, time-consuming and ethically problematic. Hence it is highly desirable to have an alternative to excessive animal trials. Thus, a simulation tool for optimising probe design can be an important benefit for the community. The challenge is to understand the interplay between the optical, neural and thermal aspects in the interaction of probe and living neural tissue. In this work, we propose a model which combines these aspects to allow clinically orientated neuroprosthetic teams to design neuroprosthetic probes for optogenetic therapies. Our model provides analyses for optical, thermal and optogenetic electrophysiological processes based on the energy equivalence and exchange among different physical fields. To validate and calibrate the model, optogenetic implantable neuroprosthetic arrayed probes based on miniature LEDs were developed. Then, optical, thermal measurement and neural photocurrent recording experiments were implemented on the probes. We can then provide analysis on exemplar arrayed neural probes.

Neuromodulation is an established treatment for numerous neurological conditions, but to expand the therapeutic scope there is a need to improve the spatial, temporal and cell-type specificity of stimulation. Optogenetics is a promising area of current research, enabling optical stimulation of genetically-defined cell types without interfering with concurrent electrical recording for closed-loop control of neural activity. We are developing an open-source system to provide a platform for closed-loop optogenetic neuromodulation, incorporating custom integrated circuitry for recording and stimulation, real-time closed-loop algorithms running on a microcontroller and experimental control via a PC interface. We include commercial components to validate performance, with the ultimate aim of translating this approach to humans. In the meantime our system is flexible and expandable for use in a variety of preclinical neuroscientific applications. The platform consists of a Controlling Abnormal Network Dynamics using Optogenetics (CANDO) Control System (CS) that interfaces with up to four CANDO headstages responsible for electrical recording and optical stimulation through custom CANDO LED optrodes. Control of the hardware, inbuilt algorithms and data acquisition is enabled via the CANDO GUI (Graphical User Interface). Here we describe the design and implementation of this system, and demonstrate how it can be used to modulate neuronal oscillations in vitro and in vivo.